69 Best Health Tech Startups in Switzerland to Watch in 2024

Advanced allosteric modulator therapeutics developer for neurological disorders.

Total Raised: $63.00M

Last Funding: $63.00M (Series A)

AI-driven augmented reality data tools provider for spinal surgery.

Total Raised: $78.76M

Last Funding: $68.00M (Series B)

Clinical-stage central nervous system (CNS) technology.

Total Raised: $169.29M

Last Funding: $110.29M (Series B)

Antibody discovery and human immune repertoire analysis platform.

Total Raised: $45.28M

Last Funding: $2.30M (Series A)

Developer of cell macroencapsulation technology to deliver therapeutic proteins beyond the human blood-brain barrier.

Total Raised: $3.86M

Last Funding: $3.86M (Seed)

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

Total Raised: $59.53M

Last Funding: $59.53M (Series A)

Therapeutics developer for mast cell-mediated diseases.

Total Raised: $3.50M

Last Funding: $3.50M (Seed)

Viral vector-based cancer vaccines developer.

Total Raised: $141.79M

Last Funding: $82.89M (Series C)

Immunotherapy platform for cancer.

Total Raised: $93.33M

Last Funding: $74.00M (Unknown)

B2B SaaS human motion analysis platform.

Total Raised: $125.00M

Last Funding: $30.00M (Unknown)

Temperature controlled containers for the pharmaceutical industry.

Total Raised: $235.00M

Last Funding: $57.00M (Series C)

Medical devices developer for spine specialist surgeons.

Total Raised: $88.10M

Last Funding: $32.50M (Series B)

Self-adjuvanting and multi-antigen vaccine technology platform.

Total Raised: $3.00M

Last Funding: $3.00M (Series A)

Medical device developer focused on tools for minimally invasive surgeries.

Total Raised: $90.00M

Last Funding: $90.00M (Series E)

Developer of an antibody-drug conjugates (ADCs).

Total Raised: $26.81M

Last Funding: $2.70M (Seed)

Biotechnology platform developing therapies by investing in people and ideas.

Total Raised: $25.31M

Last Funding: $0.00M (Unknown)

Healthcare procurement platform.

Total Raised: $2.00M

Last Funding: $2.00M (Seed)

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.

Total Raised: $50.00M

Last Funding: $50.00M (Series A)

Manufacturer of drugs to combat the effects of ageing.

Total Raised: $10.90M

Last Funding: $10.90M (Series A)

Platform to monitor patient’s health and optimise care.

Total Raised: $9.58M

Last Funding: $9.58M (Series A)

Developer of treatments for neurodegenerative diseases.

Total Raised: $100.00M

Last Funding: $100.00M (Series C)

Clinically tested, patent-protected dietary therapy for migraines.

Total Raised: $4.80M

Last Funding: $4.80M (Seed)

Cardiac ablation system developer for treating cardiac arrhythmias.

Total Raised: $58.61M

Last Funding: $58.61M (Series B)

Planted is a food processing company that specializes in plant-based meals.

Total Raised: $110.52M

Last Funding: $71.34M (Series B)

Longevity health products maker.

Total Raised: $74.48M

Last Funding: $9.60M (Series C)

True precision medicine through single-cell science

Total Raised: $5.90M

Last Funding: $1.80M (Series A)

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.

Total Raised: $23.00M

Last Funding: $2.60M (Seed)

Platform for observing live cells in 3D without damaging them.

Total Raised: $22.20M

Last Funding: $20.00M (Unknown)

Platform providing digital assessments and therapies for patient treatment and rehabilitation.

Total Raised: $125.00M

Last Funding: $125.00M (Unknown)

Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist.

Total Raised: $80.00M

Last Funding: $80.00M (Series C)

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

Total Raised: $30.00M

Last Funding: $30.00M (Series A)

Personal care products manufacturing company.

Total Raised: $4.18M

Last Funding: $4.18M (Seed)

Home-test kit to perform blood tests.

Total Raised: $28.10M

Last Funding: $10.70M (Series B)

Program to increase human lifespan.

Total Raised: $5.86M

Last Funding: $5.86M (Seed)

Glycanengineering platform.

Total Raised: $49.29M

Last Funding: $49.29M (Series A)

Clinical-stage biotechnology developing treatments for cancer.

Total Raised: $85.50M

Last Funding: $85.50M (Series B)

Developer of fibrotic encapsulation solutions in implantable medical devices.

Total Raised: $9.41M

Last Funding: $0.11M (Pre Seed)

Non-invasive treatment for heart arrhythmias.

Total Raised: $15.70M

Last Funding: $15.70M (Series A)

Treatments that improve the lives of cancer patients with innovative approaches.

Total Raised: $26.73M

Last Funding: $26.73M (Series C)

Real-time analysis of head impact in athletes.

Total Raised: $1.39M

Last Funding: $1.39M (Seed)

AI for early cancer detection.

Total Raised: $25.91M

Last Funding: $25.91M (Series C)

Small molecule mitophagy inducers developer.

Total Raised: $20.66M

Last Funding: $20.66M (Series A)

Software platform that accelerates innovation in the pharmaceutical industry.

Total Raised: $12.70M

Last Funding: $12.70M (Seed)

Brain positron emission tomography (PET) scanners designed specifically for accurate diagnosis and imaging.

Total Raised: $9.67M

Last Funding: $5.50M (Series B)

AI-based tool that assesses patients' risk of cognitive impairment after surgery.

Total Raised: $3.60M

Last Funding: $2.16M (Seed)

Intelligent healthcare warning systems.

Total Raised: $12.38M

Last Funding: $10.43M (Series A)

Patient-centred platform for medical image storage and communication.

Total Raised: $3.03M

Last Funding: $1.85M (Seed)

Fertility-tracking bracelet maker.

Total Raised: $16.91M

Last Funding: $2.60M (Seed)

AI-powered hypertension management platform.

Total Raised: $31.16M

Last Funding: $0.45M (Seed)

Platform offering tools to enhance the development of personalized and precision medicine.

Total Raised: $35.31M

Last Funding: $20.31M (Unknown)

Software platform to identify and analyze key opinion leaders in specific therapeutic areas.

Total Raised: $12.59M

Last Funding: $12.59M (Unknown)

Clinical-stage biopharmaceutical company developing drugs for rare diseases.

Total Raised: $16.00M

Last Funding: $16.00M (Series A)

Blood purification platform.

Total Raised: $15.56M

Last Funding: $15.56M (Series B)

Gene therapy platform.

Total Raised: $6.81M

Last Funding: $6.81M (Seed)

Technology for easy and painless blood collection accessible to everyone.

Total Raised: $6.40M

Last Funding: $6.40M (Series A)

Software that ensures quality management and standardization of clinical procedures in radiology using artificial intelligence.

Total Raised: $4.07M

Last Funding: $4.07M (Series A)

Clinical biotech firm focused on revolutionizing cell invasion research.

Total Raised: $4.70M

Last Funding: $4.70M (Seed)

Platform engineering next-generation T cell receptor therapies.

Total Raised: $15.80M

Last Funding: $15.80M (Seed)

Neuro-interventional products developer for stroke and aneurysms.

Total Raised: $6.00M

Last Funding: $6.00M (Series A)

Solution offering simple and cost-effective needle guidance.

Total Raised: $3.20M

Last Funding: $3.20M (Seed)

Automated visual inspection for pharma.

Total Raised: $0.88M

Last Funding: $0.88M (Seed)

Next-generation laboratory equipment developers.

Total Raised: $13.46M

Last Funding: $13.46M (Series A)

Spine surgical robotic systems.

Total Raised: $9.37M

Last Funding: $9.37M (Series A)

Medtech startup developing light-activated medical fillers for faster, more efficient surgeries.

Total Raised: $2.58M

Last Funding: $2.58M (Seed)

Quantum sensing technology for nanoscale imaging.

Total Raised: $7.08M

Last Funding: $4.46M (Series A)

SaaS platform that simplifies and enhances patient education.

Total Raised: $2.71M

Last Funding: $1.98M (Seed)

Startup based in Zürich focused on enabling the medical community to provide healthcare at home.

Total Raised: $5.74M

Last Funding: $4.81M (Series A)

Medical device that uses virtual reality and artificial intelligence for early neurological disorder diagnosis.

Total Raised: $4.82M

Last Funding: $3.30M (Seed)

Near-eye light-field display technology providing true optical depth and better immersion for virtual and mixed reality experiences.

Total Raised: $11.42M

Last Funding: $4.30M (Unknown)